The Avon River Hawks may have started the postseason as the No. 5 seed in Section V Class B2, but they are quickly emerging ...
Eli Lilly has struck a deal worth up to $1.9 billion with Boston biotech Ascidian Therapeutics to develop treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results